Ancora Advisors LLC lessened its stake in shares of Varex Imaging (NASDAQ:VREX - Free Report) by 70.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 55,655 shares of the company's stock after selling 134,805 shares during the quarter. Ancora Advisors LLC owned about 0.14% of Varex Imaging worth $646,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in the company. Stifel Financial Corp acquired a new stake in shares of Varex Imaging during the 4th quarter valued at approximately $457,000. Price T Rowe Associates Inc. MD raised its holdings in Varex Imaging by 22.3% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,411 shares of the company's stock valued at $225,000 after acquiring an additional 2,807 shares during the last quarter. Northern Trust Corp lifted its position in Varex Imaging by 1.6% during the fourth quarter. Northern Trust Corp now owns 444,694 shares of the company's stock worth $6,488,000 after buying an additional 7,123 shares during the period. Comerica Bank increased its stake in shares of Varex Imaging by 39.8% during the 4th quarter. Comerica Bank now owns 46,924 shares of the company's stock valued at $685,000 after acquiring an additional 13,370 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its position in Varex Imaging by 111.7% during the fourth quarter. Ameriprise Financial Inc. now owns 157,842 shares of the company's stock worth $2,303,000 after purchasing an additional 83,277 shares during the last quarter.
Varex Imaging Price Performance
VREX traded up $0.54 on Thursday, reaching $11.50. The company had a trading volume of 367,444 shares, compared to its average volume of 368,631. The company has a market capitalization of $477.25 million, a P/E ratio of -3.58 and a beta of 0.87. The company has a current ratio of 3.51, a quick ratio of 1.82 and a debt-to-equity ratio of 0.78. The company has a fifty day moving average of $9.46 and a 200-day moving average of $9.37. Varex Imaging has a one year low of $6.76 and a one year high of $16.93.
Varex Imaging (NASDAQ:VREX - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.14. Varex Imaging had a positive return on equity of 5.54% and a negative net margin of 16.13%.The business had revenue of $203.00 million for the quarter, compared to analysts' expectations of $190.32 million. Varex Imaging has set its Q4 2025 guidance at 0.100-0.300 EPS. As a group, equities research analysts anticipate that Varex Imaging will post 0.53 earnings per share for the current year.
Analyst Ratings Changes
Several research analysts recently commented on VREX shares. B. Riley restated a "buy" rating and issued a $16.00 price target (up previously from $12.00) on shares of Varex Imaging in a report on Friday, August 8th. Wall Street Zen lowered shares of Varex Imaging from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 9th. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus price target of $19.50.
Check Out Our Latest Report on Varex Imaging
Varex Imaging Company Profile
(
Free Report)
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Read More

Before you consider VAREX IMAGING, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and VAREX IMAGING wasn't on the list.
While VAREX IMAGING currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.